EXCLUSIVE: ‘32% Ditch Painkillers For Cannabis,’ Says Bloomberg Analyst

In the latest episode of Benzinga’s Cannabis Insider, Kenneth Shea, the senior consumer products analyst at Bloomberg Intelligence, revealed findings from the BI 2024 Cannabis Survey that are shaking up the cannabis industry.

With findings revealing a shift toward cannabis as a substitute for traditional painkillers and alcohol and a preference for smoking and edibles among consumers, the survey shows the landscape of cannabis use is evolving. 

A Natural Alternative To Painkillers and Alcohol?

Shea spotlighted a substantial shift toward cannabis as an alternative to traditional painkillers and alcohol. “We’re witnessing a considerable pivot in consumer habits, with 32% of our survey participants choosing cannabis over painkillers and 33% over alcohol,” Shea said.

This trend underscores a broader acceptance of cannabis as a wellness product, potentially shaking up the pharmaceutical and alcohol industries.

The Timeless Appeal Of Smoking, Edibles

Traditional consumption methods remain dominant, the survey shows. “A majority, 72%, …

Full story available on Benzinga.com